Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder

Clinical trial NCT00601367 · COMPLETED

Trial details

NCT number: NCT00601367
Sponsor: Sprout Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sexual Dysfunctions, Psychological

Start date: 2008-01-01
Primary completion: 2009-10-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.